| Any specific phobia | Any early-onset specific phobia | Number of subtypes | Test of linear effect | ||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4+ | Â | ||||
% (SE) | % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | OR (95% CI) | p value | |
Lifetime prevalence | 7.6 (0.1) | 5.9 (0.1) | 3.3 (0.1) | 1.5 (0.0) | 0.6 (0.0) | 0.5 (0.0) | – | – |
12-month prevalence | 5.7 (0.1) | 4.4 (0.1) | 2.4 (0.1) | 1.1 (0.0) | 0.5 (0.0) | 0.4 (0.0) | – | – |
Persistence | 74.3 (0.6) | 75.2 (0.7) | 73.4 (0.9) | 75.2 (1.3) | 77.6 (1.8) | 85.2 (1.8) | 1.2* (1.1–1.3) | < 0.001 |
Severe disability | 19.1 (0.6) | 19.7 (0.6) | 17.5 (0.8) | 20.2 (1.4) | 24.0 (2.0) | 26.5 (2.4) | 1.3* (1.1–1.4) | < 0.001 |
Treatment for specific phobia | 22.4 (0.5) | 20.8 (0.6) | 19.1 (0.8) | 22.9 (1.2) | 22.4 (1.7) | 22.8 (2.0) | 1.1* (1.0–1.2) | 0.004 |